Anand Rathi's research report on Sharda Cropchem
Powered by its focus on registering formulations and active ingredient across regions, Sharda’s strong growth would continue. A strong pipeline and distribution network would add to growth. Internallyfunded capex and FCF generation would strengthen its balance sheet, resulting in higher return ratios.
We initiate coverage on Sharda Cropchem, with a Buy rating and a target price of Rs.480.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.